About 11 results found for searched term "88-04-0" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5513 | Chloroxylenol | Antibiotic |
| 4-Chloro-3,5-dimethylphenol; PCMX | ||
| Chloroxylenol is a broad-spectrum antimicrobial chemical compound used to control bacteria, algae, fungi and virus. | ||
| M8730 | INI-43 | Others |
| INI-43 is a cell penetrant and potent inhibitor of Kpnb1-mediated nuclear import that cancer cell death via a G2–M cell cycle arrest followed by apoptosis. | ||
| M8800 | T3MG | Others |
| T3MG is a selective inhibitor of excitatory amino acid transporters GLT-1, EAAT2, and EAAT4. | ||
| M9483 | Azeliragon | Others |
| TTP488; PF-04494700 | ||
| Azeliragon is a potent and orally active RAGE inhibitor. | ||
| M13908 | AVE 0991 sodium salt | Angiotensin Receptor |
| AVE 0991 sodium salt is a nonpeptide and orally active Ang-(1-7) receptor Mas agonist. AVE 0991 competes for high-affinity binding of [125I]-Ang-(1-7) to bovine aortic endothelial cell membranes with IC50 of 21 nM. | ||
| M14512 | MAFP | Phospholipase |
| Methyl Arachidonyl Fluorophosphonate | ||
| MAFP (Methyl Arachidonyl Fluorophosphonate) is an selective, active-site directed and irreversible inhibitor of cPLA2 and iPLA2. MAFP is also a potent irreversible inhibitor of anandamide amidase. | ||
| M21967 | Cefepime | Antibiotic |
| Cefepime is a semisynthetic, broad-spectrum, fourth-generation cephalosporin with antibacterial activity. Cefepime binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. | ||
| M24868 | Zenocutuzumab | EGFR/HER2 |
| MCLA-128; PB4188; R040517 | ||
| Zenocutuzumab (MCLA-128) is a bispecific humanized IgG1 antibody containing two different Fab arms, targeting extracellular domains of HER2 and HER3. | ||
| M30810 | LY2389575 hydrochloride | GluR |
| LY2389575 hydrochloride is a selective and noncompetitive mGlu3 negative allosteric modulator (NAM), with an IC50 value of 190 nM. LY2389575 hydrochloride induces an increase in Mrc1 levels. LY2389575 hydrochloride also independently amplifies Amyloid beta (Aβ) toxicity and can be used in study of Alzheimer's disease. | ||
| M31227 | Lirafugratinib hydrochloride | EGFR/HER2 |
| RLY-4008 hydrochloride | ||
| Lirafugratinib hydrochloride is an orally active selective inhibitor of FGFR2. | ||
| M45351 | Surinabant | Cannabinoid |
| SR147778 | ||
| Surinabant is a selective, high affinity, orally active cannabinoid receptor type 1 CB1R antagonist. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
